Report of the 6th International Workshop on PET in lymphoma

Cristina Nanni, Anne Ségolène Cottereau, Egesta Lopci, Caroline Bodet-Milin, Monica Coronado, Barbara Pro, Wong Seog Kim, Judith Trotman, Sally Barrington, Ulrich Duhrsen, Thierry Vander Borght, Elena Zamagni, Françoise Kraeber-Bodéré, Christina Messiou, Alain Rahmouni, Irène Buvat, Marc Andre, Mark Hertzberg, Wim Oyen, Olivier CasasnovasStefano Luminari, Laurent Garderet, Françoise Montravers, Carsten Kobe, Regine Kluge, Annibale Versari, Emanuele Zucca, Philippe Moreau, Bruce Cheson, Corinne Haioun, Andrea Gallamini, Michel Meignan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.

Original languageEnglish
Pages (from-to)2298-2303
Number of pages6
JournalLeukemia and Lymphoma
Volume58
Issue number10
DOIs
Publication statusPublished - Oct 2017

Fingerprint

Positron-Emission Tomography
Lymphoma
Education
Multiple Myeloma
Peripheral T-Cell Lymphoma
Posters
Nuclear Medicine
Hodgkin Disease
France
Therapeutics
Guidelines
Physicians
Neoplasms

Keywords

  • Journal Article

Cite this

Nanni, C., Cottereau, A. S., Lopci, E., Bodet-Milin, C., Coronado, M., Pro, B., ... Meignan, M. (2017). Report of the 6th International Workshop on PET in lymphoma. Leukemia and Lymphoma, 58(10), 2298-2303. https://doi.org/10.1080/10428194.2017.1298752

Report of the 6th International Workshop on PET in lymphoma. / Nanni, Cristina; Cottereau, Anne Ségolène; Lopci, Egesta; Bodet-Milin, Caroline; Coronado, Monica; Pro, Barbara; Kim, Wong Seog; Trotman, Judith; Barrington, Sally; Duhrsen, Ulrich; Vander Borght, Thierry; Zamagni, Elena; Kraeber-Bodéré, Françoise; Messiou, Christina; Rahmouni, Alain; Buvat, Irène; Andre, Marc; Hertzberg, Mark; Oyen, Wim; Casasnovas, Olivier; Luminari, Stefano; Garderet, Laurent; Montravers, Françoise; Kobe, Carsten; Kluge, Regine; Versari, Annibale; Zucca, Emanuele; Moreau, Philippe; Cheson, Bruce; Haioun, Corinne; Gallamini, Andrea; Meignan, Michel.

In: Leukemia and Lymphoma, Vol. 58, No. 10, 10.2017, p. 2298-2303.

Research output: Contribution to journalArticle

Nanni, C, Cottereau, AS, Lopci, E, Bodet-Milin, C, Coronado, M, Pro, B, Kim, WS, Trotman, J, Barrington, S, Duhrsen, U, Vander Borght, T, Zamagni, E, Kraeber-Bodéré, F, Messiou, C, Rahmouni, A, Buvat, I, Andre, M, Hertzberg, M, Oyen, W, Casasnovas, O, Luminari, S, Garderet, L, Montravers, F, Kobe, C, Kluge, R, Versari, A, Zucca, E, Moreau, P, Cheson, B, Haioun, C, Gallamini, A & Meignan, M 2017, 'Report of the 6th International Workshop on PET in lymphoma', Leukemia and Lymphoma, vol. 58, no. 10, pp. 2298-2303. https://doi.org/10.1080/10428194.2017.1298752
Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B et al. Report of the 6th International Workshop on PET in lymphoma. Leukemia and Lymphoma. 2017 Oct;58(10):2298-2303. https://doi.org/10.1080/10428194.2017.1298752
Nanni, Cristina ; Cottereau, Anne Ségolène ; Lopci, Egesta ; Bodet-Milin, Caroline ; Coronado, Monica ; Pro, Barbara ; Kim, Wong Seog ; Trotman, Judith ; Barrington, Sally ; Duhrsen, Ulrich ; Vander Borght, Thierry ; Zamagni, Elena ; Kraeber-Bodéré, Françoise ; Messiou, Christina ; Rahmouni, Alain ; Buvat, Irène ; Andre, Marc ; Hertzberg, Mark ; Oyen, Wim ; Casasnovas, Olivier ; Luminari, Stefano ; Garderet, Laurent ; Montravers, Françoise ; Kobe, Carsten ; Kluge, Regine ; Versari, Annibale ; Zucca, Emanuele ; Moreau, Philippe ; Cheson, Bruce ; Haioun, Corinne ; Gallamini, Andrea ; Meignan, Michel. / Report of the 6th International Workshop on PET in lymphoma. In: Leukemia and Lymphoma. 2017 ; Vol. 58, No. 10. pp. 2298-2303.
@article{9428dd84df59414296bb05a02652c9bb,
title = "Report of the 6th International Workshop on PET in lymphoma",
abstract = "Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.",
keywords = "Journal Article",
author = "Cristina Nanni and Cottereau, {Anne S{\'e}gol{\`e}ne} and Egesta Lopci and Caroline Bodet-Milin and Monica Coronado and Barbara Pro and Kim, {Wong Seog} and Judith Trotman and Sally Barrington and Ulrich Duhrsen and {Vander Borght}, Thierry and Elena Zamagni and Fran{\cc}oise Kraeber-Bod{\'e}r{\'e} and Christina Messiou and Alain Rahmouni and Ir{\`e}ne Buvat and Marc Andre and Mark Hertzberg and Wim Oyen and Olivier Casasnovas and Stefano Luminari and Laurent Garderet and Fran{\cc}oise Montravers and Carsten Kobe and Regine Kluge and Annibale Versari and Emanuele Zucca and Philippe Moreau and Bruce Cheson and Corinne Haioun and Andrea Gallamini and Michel Meignan",
year = "2017",
month = "10",
doi = "10.1080/10428194.2017.1298752",
language = "English",
volume = "58",
pages = "2298--2303",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "10",

}

TY - JOUR

T1 - Report of the 6th International Workshop on PET in lymphoma

AU - Nanni, Cristina

AU - Cottereau, Anne Ségolène

AU - Lopci, Egesta

AU - Bodet-Milin, Caroline

AU - Coronado, Monica

AU - Pro, Barbara

AU - Kim, Wong Seog

AU - Trotman, Judith

AU - Barrington, Sally

AU - Duhrsen, Ulrich

AU - Vander Borght, Thierry

AU - Zamagni, Elena

AU - Kraeber-Bodéré, Françoise

AU - Messiou, Christina

AU - Rahmouni, Alain

AU - Buvat, Irène

AU - Andre, Marc

AU - Hertzberg, Mark

AU - Oyen, Wim

AU - Casasnovas, Olivier

AU - Luminari, Stefano

AU - Garderet, Laurent

AU - Montravers, Françoise

AU - Kobe, Carsten

AU - Kluge, Regine

AU - Versari, Annibale

AU - Zucca, Emanuele

AU - Moreau, Philippe

AU - Cheson, Bruce

AU - Haioun, Corinne

AU - Gallamini, Andrea

AU - Meignan, Michel

PY - 2017/10

Y1 - 2017/10

N2 - Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.

AB - Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.

KW - Journal Article

U2 - 10.1080/10428194.2017.1298752

DO - 10.1080/10428194.2017.1298752

M3 - Article

C2 - 28264597

VL - 58

SP - 2298

EP - 2303

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 10

ER -